About this study
Children who survive acute lymphoblastic leukemia (ALL) may have health problems later in life. Cancer treatment, stress, and conditions in the places where they live may affect their bodies over time. Researchers need better ways to study these effects.
The FARSC study will involve collecting samples of blood, hair, fingernails, and saliva (spit) from survivors and siblings. The study will look at whether families can collect samples and do study tasks at home. It will also see how families feel about these tasks.
Survivors and siblings will answer questions and wear a device that tracks sleep. They will collect saliva samples at home for 3 days. If possible, these will be 3 days in a row. Caregivers will also answer questions.
What we learn from this study may help researchers plan a larger study about the long-term health of children and teens who had ALL.
Eligibility overview
- 8–18 years old
- Cancer-free
- Followed in the St. Jude After Completion of Care (ACT) Clinic
- Diagnosed with acute lymphoblastic leukemia at least 5 years ago and completed treatment at least 2 years ago
- Received treatment on the St. Jude TOT16 or TOT17 clinical trial
- Did not receive radiation to the head
- Has internet access
Survivors do not need a sibling to enroll. A sibling may take part only if the survivor enrolls.